Funding Amount

Not stated

Deadline

Deadline not published

Grant Type

Foundation

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

  • The principal investigator (PI) of the award proposal submitted

Other requirements

  • _You can learn more about this opportunity by visiting the funder's [website](https://www.aspet.org/aspet/meetings-awards/aspet-awards/aspet-scientific-achievement-awards/the-david-lehr-award)._
  • Applicants for this award must be at least 45 years of age by the nomination deadline of the year in which they are applying
  • The applicant must be a current ASPET member in good standing
  • The applicant may only submit one (1) application per award cycle

Not eligible / not funded

  • Not eligible: No candidate may be nominated for more than one major ASPET award in any given year
  • Not eligible: The current Council president and secretary/treasurer are ineligible during their active tenure
  • Not eligible: Members of the Awards Committee are not eligible to be nominated for an award
  • Not eligible: If nominated for an award, an Awards Committee member must stand down for that year and be replaced by a temporary member chosen by the Awards Committee Chair and approved by the Awards Committee
  • Not eligible: Facilities
  • Not eligible: Administrative costs
  • Not eligible: Travel
  • Not eligible: No indirect costs will be provided

Overview

_NOTE:  This award is presented biennially, in odd-numbered years. The nomination is due at the deadline._

The David Lehr Award

The David Lehr Research Award is intended to extend funding for preclinical or clinical research directed towards improving human health. This award is made possible by an endowment to ASPET from Mrs. Lisa Lehr in honor of her husband, the late Dr. David Lehr, former chair of the Department of Pharmacology for New York Medical College.

We encourage applications from the following:

  • An investigator who requires "bridging" funds to enhance a grant application for competitive renewal,
  • An investigator who has a research project currently supported by a "no cost extension" and desires additional funds to enhance a grant resubmission, or
  • An investigator who desires funds to acquire preliminary data in support of a new grant submission.

The award is presented biennially in odd-numbered years, at the award ceremony during the ASPET Annual Meeting.

The award consists of:

  • $50,000 per year for two years ($100,000 total)
  • A commemorative plaque
  • Complimentary registration and travel expenses for the winner and spouse to attend the award presentation at the ASPET Annual Meeting

Criteria and Selection

The award will be given to an ASPET member whose research, either preclinical or clinical, may introduce novel pharmacologic approaches or technologies focusing on advancing human health care, and have a clear need for such funding to maintain research productivity.

  • The awarded funds must be used to support research activities for which there is a gap in funding or for the purpose of acquiring preliminary data to support the submission of a new grant proposal.
  • The purchase of large equipment may be covered, but this must be justified in the application.
  • The award may be used to support the salaries of the principal investigator (PI), postdoctoral fellows, or research staff whose efforts are directed toward the aims of the proposal.
  • Awards will be made to the employing institution of the PI for the sole use by the PI.
  • All publications resulting from the award must acknowledge the ASPET David Lehr Research Award as a source of funding.

The application for the award will be evaluated based on the following criteria:

  • Significance – Does the project address an important problem or a critical barrier to progress in the field?
  • Investigator(s) – Are the PI and other collaborators well-suited to the project?
  • Approach – Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project?
  • Need – Does the applicant have a demonstrated need for funding keeping in mind the intent of the award?
  • Feasibility – Is the proposed research feasible given the funding and duration provided by the award?

Encouraging Diversity

ASPET is strongly committed to providing opportunities to all its members regardless of race, color, age, gender, sexual orientation, gender identity, or ability/disability. Applications from and for members of marginalized and underrepresented communities are greatly encouraged.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

  • Applicants for this award must be at least 45 years of age by the nomination deadline of the year in which they are applying.
  • The applicant must be a current ASPET member in good standing.
  • The applicant must be the principal investigator (PI) of the award proposal submitted.
  • The applicant may only submit one (1) application per award cycle.

_You must be a member of this organization to apply for this award - become a member._

Ineligibility

  • No candidate may be nominated for more than one major ASPET award in any given year.
  • The current Council president and secretary/treasurer are ineligible during their active tenure.
  • Members of the Awards Committee are not eligible to be nominated for an award.
    • If nominated for an award, an Awards Committee member must stand down for that year and be replaced by a temporary member chosen by the Awards Committee Chair and approved by the Awards Committee.
  • The awarded funds will not support facilities and administrative costs or travel.
  • No indirect costs will be provided.

Past recipients of this program

Recent awards under this program (from American Society for Pharmacology & Experimental Therapeutics Incorporated's IRS filings)

2 grants in American Society for Pharmacology & Experimental Therapeutics Incorporated's 2020 filings reference “David Lehr Award” in their stated purpose. Amounts and places as reported by the funder.

What American Society for Pharmacology & Experimental Therapeutics Incorporated actually gave

Source: IRS Form 990, 2024

Grants in 2024
5
Total given
$276K
Median grant
$55K
  • By dollars: California 20%, Texas 20%, Washington 20%. Top recipient cities: Shreveport, CA; San Anotnio, TX; Spokane, WA.
  • 0% of grants with a stated purpose were for general or operating support.

Example grants

  • LSU Health Shreveport · Shreveport, CA

    Institutional surf award

    $55K

  • Uthscsa · San Anotnio, TX

    Institutional surf award

    $55K

  • Washington State University · Spokane, WA

    Institutional surf award

    $55K

  • Pacific University · Forest Grove, OR

    Institutional surf award

    $55K

  • University of Arkansas · Fayetteville, AR

    Institutional surf award

    $55K

IRS Form 990, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for The David Lehr Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found The David Lehr Award. Now let's win it.

Start writing